Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Neoplasms 9Breast Neoplasms 8Colonic Neoplasms 5Prostatic Neoplasms 4Lung Neoplasms 4Respiratory Aspiration 3Brain Neoplasms 3Supratentorial Neoplasms 2Rectal Neoplasms 2Pituitary Neoplasms 2Patient Satisfaction 2Emergence Delirium 2Agnosia 2Uterine Neoplasms 1Urinary Bladder Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Seizures 1Respiration Disorders 1Recovery 1Rare Diseases 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Complications 1Postoperative Cognitive Complications 1Polyps 1Pain, Postoperative 1Pain 1Overweight 1Obesity 1Neurofibromatoses 1

Interventions

Surveys and Questionnaires 2Imatinib Mesylate 2tipifarnib 1pirfenidone 1nilotinib 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1Sunitinib 1Sirolimus 1Sevoflurane 1Propofol 1Percutaneous Collagen Induction 1Nitrous Oxide 1Magnetic Resonance Spectroscopy 1Lidocaine 1Glycopyrrolate 1Dexmedetomidine 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Neurofibromatoses × Propofol × Clear all
NCT03513757 2020-02-21

Dexmedetomidine and Propofol for Pediatric MRI Sedation

Medical College of Wisconsin

Phase 4 Completed
40 enrolled 15 charts
CNS

Abdominal Neoplasms, Epilepsy, Headache, Hydrocephalus, Neoplasms, Neurofibromatoses

Data powered by HemOnc (CC BY 4.0) Colophon âš¡